Reno, Nevada, sits in a region known for outdoor recreation, but for the 30.7% of Nevada adults living with obesity, the gap between the active Mountain West ideal and daily reality can feel wide. Semaglutide (Ozempic / Wegovy) offers a medically backed bridge — reducing appetite and supporting 15-20% of body weight average body weight loss. Weight Method delivers it to Reno starting at $199/month.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Reno is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Reno, NV. Weight Method offers compounded semaglutide, prescribed by licensed providers, from $199/month with virtual consultations and direct-to-door shipping.
Semaglutide targets the biological mechanisms that make sustained weight loss so difficult. By slowing gastric emptying and reducing hunger signals in the brain, it creates a consistent caloric deficit without the willpower battle of traditional dieting. Administered as a once-weekly injection, Semaglutide fits into even the busiest schedules. Weight Method prescribes it to eligible Reno, NV residents through a fully virtual process — no clinic visits, no wait times — with treatment plans starting at $199/month.
Research confirms that Semaglutide is effective across all ethnic groups, but outcomes improve when care is culturally informed. In Reno, Weight Method pairs Semaglutide treatment with bilingual support that respects the cultural context of our patients — from dietary guidance that accounts for traditional foods to communication in the language you are most comfortable with.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Nevada and start Semaglutide from $199/month.
Get Started NowFree consultation. No commitment.